Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cassava Sciences (NASDAQ: SAVA ) stands to gain a good deal this year. This will all depend on the company’s Phase 3 clinical trials progress in the results on actual patients with Alzheimer’s disease. S...
Shares of clinical-stage biotech Cassava Sciences (NASDAQ: SAVA) soared in 2021 for a couple of reasons. First, the company produced strong results in clinical studies for its potential therapy for Alzheimer's disease (AD), Simufilam. The other reason is the result of Biogen , a...
After several years of outstanding returns for the stock market, investors may be wondering how long the good times can last. Although the market may climb or fall, individual companies will continue to innovate and grow. That's why we asked three contributors to Fool.com to choose a stock ...
Palm Beach, FL –January 4, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease is a degenerative, progressive ailment that attacks the brain’s nerve cells, resulting in memory loss, behavioral changes as well as changes in think...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It may have been the hottest investing trend of 2021. But as the new year beckons, it’s tough to be bullish on meme stocks. With numerous uncertainties clouding the market , the top names in this category, AMC Ente...
3 Health Care Stocks To Check Out For The New Year Even with the stock market seemingly riding a potential Santa rally this week, the pandemic continues to rage on. As a result, investors may want to consider keeping an eye on health care stocks now. To highlight, the Omicro...
New website (www.Rethink-ALZ.com) is intended to increase visibility and information for potential study participants. Rethink-ALZ.com connects patients with nearest participating clinical site. Phase 3 efficacy studies now in over 25 clinical sites acr...
Since August this year, Cassava Sciences, an Alzheimer's Disease (AD) drug developer, has been immersed in controversy, as a Citizen Petition (CP) was filed with the FDA. I look at documents and statements from both sides to date. I share my thoughts here. For further detail...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Naked Brand (NASDAQ: NAKD ) stock is in the news today as investors react to the company’s reverse stock split for Tuesday. Source: NazarBazar/Shutterstock.com That reverse stock split saw the company ...
News, Short Squeeze, Breakout and More Instantly...
Cassava Sciences, Inc. (NASDAQ: SAVA) is one of today's top gainers. The company's shares have moved 24.9% on the day to $12.59. Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.6% to $117.99 on volume of 383,510,118 shares Aptevo Therapeutics Inc. (APVO) rose 73.4% to $0.581 on volume of 315,289,581 shares PROSHARES TRUST (SQQQ) rose 8.7% to $8.11 on volume of 173,682,364 sha...
A look at the top 10 most actives in the United States Aptevo Therapeutics Inc. (APVO) rose 45.1% to $0.486 on volume of 64,992,551 shares Verb Technology Company Inc. (VERB) rose 3.5% to $0.1205 on volume of 54,410,242 shares NVIDIA Corporation (NVDA) fell 4.4% to $120.752 on volume of 4...